Skip to main content

Series B Biotechnology Companies

Explore 428 biotechnology startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
428
Total Funding
$1.9B
Avg Funding
$75.7M
Cities
21

Export 428 Series B Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Nashville, United States
$65.0M
raised

August Bioservices is an expert, collaborative, drug discovery, clinical development, and clinical manufacturing company.

Dec 2022
Series B

Founder Contacts

30,000+ verified contacts

Springfield, United States
$4.8M
raised

Stony Creek Colors is engaged in the production of bio-based dyes together with farmers, mills, and brands.

Dec 2022
Series B

Founder Contacts

30,000+ verified contacts

Basel, Switzerland
$147.2M
raised

Noema Pharma is a biotech company that develops therapies to address disabling symptoms in conditions of the brain and nervous system.

Dec 2024
Series B

Founder Contacts

30,000+ verified contacts

San Diego, United States
$84.0M
raised

BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.

Dec 2025
Series B

Founder Contacts

30,000+ verified contacts

Munich, Germany
$64.6M
raised

Orbem provides AI-powered imaging and analytics solutions to deliver non-invasive biological insights.

Jan 2026
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 428 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Heidelberg, Germany
$59.4M
raised

Exciva develops clinical-stage biopharmaceutical therapies focused on addressing neuropsychiatric symptoms associated with dementia.

Jan 2026
Series B

Founder Contacts

30,000+ verified contacts

Martinsried, Germany
$15.3M
raised

PreOmics is a company that develops and produces innovative technologies for the pre-analytics of samples for mass spectrometry.

Jan 2022
Series B

Founder Contacts

30,000+ verified contacts

Seattle, United States
$105.0M
raised

Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics.

Nov 2021
Series B

Founder Contacts

30,000+ verified contacts

Paris, France
$17.4M
raised

PathoQuest is a biotech company developing NGS-based metagenomic tests for exhaustive identification of pathogens.

Nov 2021
Series B

Founder Contacts

30,000+ verified contacts

San Diego, United States
$20.0M
raised

Mingsight Pharmaceuticals is a pharmaceutical company engaged in developing ophthalmic medical drugs.

Nov 2021
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 428 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
London, United Kingdom
$100.0M
raised

Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments.

Jan 2022
Series B

Founder Contacts

30,000+ verified contacts

Paris, France
$20.7M
raised

nextProtein develops a new large-scale technology that produces a sustainable source of protein.

Nov 2025
Series B

Founder Contacts

30,000+ verified contacts

Watertown, United States
$75.5M
raised

Platelet Biogenesis is an allogeneic cell therapy company that focuses on platelet biology.

Nov 2021
Series B

Founder Contacts

30,000+ verified contacts

Milano, Italy
$141.0M
raised

AAVantgarde Bio is a clinical-stage biotechnology company that develops gene therapies for inherited retinal disorders.

Nov 2025
Series B

Founder Contacts

30,000+ verified contacts

Mont-saint-guibert, Belgium
$23.4M
raised

Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.

Nov 2022
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 428 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Atlanta, United States
$75.0M
raised

Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.

Nov 2021
Series B

Founder Contacts

30,000+ verified contacts

San Francisco, United States
$67.0M
raised

Vial is a hyper scalable biotech — advancing programs into the clinic with lower cost trials and computationally designed therapeutics.

Nov 2022
Series B

Founder Contacts

30,000+ verified contacts

La Rochelle, France
$8.3M
raised

Meccellis Biotech specializes in tissue and cell engineering.

Nov 2022
Series B

Founder Contacts

30,000+ verified contacts

London, United Kingdom
$156.0M
raised

Quell Therapeutics is a cell therapy company

Nov 2021
Series B

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$60.0M
raised

Ethyreal Bio is a biotechnology startup developing precision therapies for autoimmune thyroid disorders.

Jan 2026
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 428 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Boston, United States
$63.5M
raised

Precede Biosciences is a biotechnology company that provides a blood-based approach to reveal disease-defining transcriptional biology.

Jan 2026
Series B

Founder Contacts

30,000+ verified contacts

San Diego, United States
$250.0M
raised

Mirador Therapeutics develops precision medicines for immune-mediated diseases.

Jan 2026
Series B

Founder Contacts

30,000+ verified contacts

Palo Alto, United States
$33.5M
raised

Juvena Therapeutics develops tissue-restorative biologics to address chronic muscle and age-related conditions.

Jan 2026
Series B

Founder Contacts

30,000+ verified contacts

Singapore, Singapore
$95.0M
raised

RWDC Industries develops sustainable biodegradable solutions, with a focus on biodegradable, water-based coatings for paper-based packaging.

Nov 2021
Series B

Founder Contacts

30,000+ verified contacts

La Jolla, United States
$140.0M
raised

Shoreline Biosciences is a biomedical company intended to establish immunotherapies for seriously ill patients.

Nov 2021
Series B

Founder Contacts

30,000+ verified contacts

Showing 376 to 400 of 428 companies

Ready to Connect with Series B Biotechnology Startups?

Get verified founder emails, funding details, and company data for 428 series b biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

428 Biotechnology Series B Startups (July 2026) — Page 16 | VCBacked